Literature DB >> 8548387

The biochemical and pharmacological activity of 9-benzyl-9-deazaguanine, a potent purine nucleoside phosphorylase (PNP) inhibitor.

E Kimble1, J Hadala, R Ludewig, P Peters, G Greenberg, G Xiao, W Guida, L McQuire, P Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8548387     DOI： 10.1007/bf01778321

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  5 in total

1.  Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).

Authors:  D A Carson; J Kaye; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Identification of nucleosides and bases in serum and plasma samples by reverse-phase high performance liquid chromatography.

Authors:  A M Krstulovic; P R Brown; D M Rosie
Journal:  Anal Chem       Date:  1977-12       Impact factor: 6.986

3.  An enzymic method for the determination of inorganic phosphate in serum.

Authors:  M Sugiura; K Kato; T Adachi; Y Ito; K Hirano; S Sawaki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-05       Impact factor: 1.645

4.  Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.

Authors:  A Cohen; D Doyle; D W Martin; A J Ammann
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

5.  Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity.

Authors:  E R Giblett; A J Ammann; D W Wara; R Sandman; L K Diamond
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.